Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenues
Revenue	$ 2,678	$ 2,272
Costs and expenses:
Cost of revenue	581	506
Operations and support	326	303
Product development	638	568
Sales and marketing	751	563
General and administrative	296	294
Total costs and expenses	2,592	2,234
Income from operations	86	38
Interest income	155	173
Other income (expense), net	40	(38)
Income before income taxes	281	173
Provision for income taxes	121	19
Net income	$ 160	$ 154
Net income per share attributable to Class A and Class B common stockholders:
Basic (in USD per share)	$ 0.27	$ 0.25
Diluted (in USD per share)	$ 0.26	$ 0.24
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic (in shares)	598	621
Diluted (in shares)	608	632

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net income	$ 160,000	$ 154,000
Adjustments to reconcile net income to cash provided by operating activities:
Stock-based compensation expense	410,000	358,000
Deferred income taxes	147,000	1,000
Other, net	34,000	95,000
Changes in operating assets and liabilities:
Prepaids and other assets	(210,000)	(79,000)
Accrued expenses and other liabilities	179,000	155,000
Unearned fees	988,000	1,105,000
Net cash provided by operating activities	1,708,000	1,789,000
Cash flows from investing activities:
Purchases of short-term investments	(1,375,000)	(766,000)
Sales and maturities of short-term investments	849,000	623,000
Other investing activities, net	65,000	(8,000)
Net cash used in investing activities	(461,000)	(151,000)
Cash flows from financing activities:
Change in funds payable and amounts payable to customers	3,707,000	3,074,000
Proceeds from issuance of long-term debt, net of issuance costs	2,483,000	0
Principal repayment of long-term debt	(2,000,000)	0
Share repurchases	(1,088,000)	(807,000)
Taxes paid related to tax on equity awards	(140,000)	(152,000)
Proceeds from exercise of equity awards	8,000	30,000
Net cash provided by financing activities	2,970,000	2,145,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(118,000)	207,000
Net increase in cash, cash equivalents, and restricted cash	4,099,000	3,990,000
Cash, cash equivalents, and restricted cash, beginning of period	13,486,000	12,760,000
Cash, cash equivalents, and restricted cash, end of period	$ 17,585,000	$ 16,750,000

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 7,037	$ 6,560
Short-term investments	4,968	4,454
Funds receivable and amounts held on behalf of customers	10,550	6,959
Prepaids and other current assets	1,046	824
Total current assets	23,601	18,797
Deferred income tax assets	1,941	2,102
Goodwill and intangible assets, net	767	770
Other assets, noncurrent	519	539
Total assets	26,828	22,208
Current liabilities:
Accrued expenses, accounts payable, and other current liabilities	3,081	2,948
Funds payable and amounts payable to customers	10,550	6,959
Current portion of long-term debt	0	1,999
Unearned fees	2,733	1,743
Total current liabilities	16,364	13,649
Long-term debt, net	2,475	0
Other liabilities, noncurrent	353	360
Total liabilities	19,192	14,009
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	14,041	13,763
Accumulated other comprehensive loss	(2)	(62)
Accumulated deficit	(6,403)	(5,502)
Total stockholders’ equity	7,636	8,199
Total liabilities and stockholders’ equity	$ 26,828	$ 22,208